Bentham Science Logo

Current Pharmacogenomics and Personalized Medicine

Formerly: Current Pharmacogenomics

Volume 17, 3 Issues, 2019
ISSN: 1875-6913 (Online)
ISSN: 1875-6921 (Print)
This journal supports open access

Aims & Scope

Current Pharmacogenomics and Personalized Medicine (CPPM) is a transdisciplinary peer-reviewed biomedical journal that reports new findings and cutting-edge concepts in both pharmacogenomics and personalized medicine under a single cover. CPPM is an accelerator for global personalized medicine and pharmacogenomics. Importantly, the journal provides a multi-disciplinary integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries.

CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer reviewed contributions from qualified authors in any global region including the Central and Latin American countries, Asia-Pacific and developing countries.

The Journal scope is defined by three inter-connected aims. First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics) as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention, and they can be mechanistically substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions such as nutrition, vaccines, surgical devices, emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy and social studies of biotechnology that collectively shape postgenomics future(s) and innovation trajectories in life sciences. Priority will be given to expert reviews/ mini-reviews and research articles that include original ideas and findings related to the journal scope and mandate.

Author Guidelines



Editor-in-Chief

Adrián LLerena, MD, Ph.D
Extremadura University
Hospital and Medical School
Badajoz, Extremadura
Spain

Journal History

Current Pharmacogenomics was launched in 2003 and later renamed in 2008 as Current Pharmacogenomics and Personalized Medicine.

Related Journals

Related eBooks

eBooks Catalog